These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17139590)

  • 1. [Pulmonary hypertension: classification, pathophysiology and noninvasive diagnosis].
    Rosenkranz S
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S295-9. PubMed ID: 17139590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostics in pulmonary hypertension.
    Schannwell CM; Steiner S; Strauer BE
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):591-602. PubMed ID: 18204173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension: evaluation of the newly diagnosed patient.
    Torbicki A; Kurzyna M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):372-8. PubMed ID: 16121313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
    Kayikçioğlu M; Kültürsay H
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of pulmonary hypertension].
    Natali D; Simonneau G; Humbert M; Montani D
    Rev Pneumol Clin; 2008 Jun; 64(3):151-61. PubMed ID: 18656791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment.
    Distler O; Pignone A
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv22-5. PubMed ID: 16980719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary arterial hypertension].
    Montani D; Hamid A; Yaïci A; Sztrymf B; Humbert M
    Rev Prat; 2004 Jan; 54(1):5-13. PubMed ID: 15049592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of exercise pulmonary arterial hypertension in scleroderma.
    Callejas-Rubio JL; Moreno-Escobar E; de la Fuente PM; Pérez LL; Fernández RR; Sánchez-Cano D; Mora JP; Ortego-Centeno N
    J Rheumatol; 2008 Sep; 35(9):1812-6. PubMed ID: 18634147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring outcomes in PAH: the gap between the measures that are used and their validity.
    Furst DE
    Ann N Y Acad Sci; 2007 Jun; 1107():410-6. PubMed ID: 17804569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary arterial hypertension in the elderly subject].
    Frachon I; Barnier A; Jobic Y; Gut-Gobert C; Etienne Y; Crutu A; Mialon P; Pasquier E; Nowak E; Mejri M; Couturaud F; Leroyer C;
    Rev Mal Respir; 2010; 27(1):30-6. PubMed ID: 20146949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early detection and treatment of pulmonary arterial hypertension].
    Lador F; Beghetti M; Rochat T
    Rev Med Suisse; 2009 Nov; 5(226):2317-21. PubMed ID: 20052863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role].
    Mukhin NA; Fomin VV; Popova EN; Kuznetsova AV; Popova IA; Churganova LIu; Osipenko VI
    Ter Arkh; 2009; 81(3):47-51. PubMed ID: 19459423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension.
    Lammers AE; Hislop AA; Haworth SG
    Int J Cardiol; 2009 Jun; 135(1):21-6. PubMed ID: 18599134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.
    Allanore Y; Borderie D; Avouac J; Zerkak D; Meune C; Hachulla E; Mouthon L; Guillevin L; Meyer O; Ekindjian OG; Weber S; Kahan A
    Arthritis Rheum; 2008 Jan; 58(1):284-91. PubMed ID: 18163505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition, classification, and epidemiology of pulmonary arterial hypertension.
    Hoeper MM
    Semin Respir Crit Care Med; 2009 Aug; 30(4):369-75. PubMed ID: 19634076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.
    Leuchte HH; Neurohr C; Baumgartner R; Holzapfel M; Giehrl W; Vogeser M; Behr J
    Am J Respir Crit Care Med; 2004 Aug; 170(4):360-5. PubMed ID: 15087298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and differential assessment of pulmonary arterial hypertension.
    Barst RJ; McGoon M; Torbicki A; Sitbon O; Krowka MJ; Olschewski H; Gaine S
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):40S-47S. PubMed ID: 15194177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension: screening and evaluation in scleroderma.
    York M; Farber HW
    Curr Opin Rheumatol; 2011 Nov; 23(6):536-44. PubMed ID: 21934501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
    Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
    Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.